332 related articles for article (PubMed ID: 21625418)
1. Place of pitavastatin in the statin armamentarium: promising evidence for a role in diabetes mellitus.
Kawai Y; Sato-Ishida R; Motoyama A; Kajinami K
Drug Des Devel Ther; 2011; 5():283-97. PubMed ID: 21625418
[TBL] [Abstract][Full Text] [Related]
2. Searching the place of pitavastatin in the current treatment of patients with dyslipidemia.
Barrios V; Escobar C; Zamorano JL
Expert Rev Cardiovasc Ther; 2013 Dec; 11(12):1597-612. PubMed ID: 24215190
[TBL] [Abstract][Full Text] [Related]
3. Pitavastatin: an overview.
Saito Y
Atheroscler Suppl; 2011 Nov; 12(3):271-6. PubMed ID: 22152281
[TBL] [Abstract][Full Text] [Related]
4. Pitavastatin: a new HMG-CoA reductase inhibitor.
Wensel TM; Waldrop BA; Wensel B
Ann Pharmacother; 2010 Mar; 44(3):507-14. PubMed ID: 20179258
[TBL] [Abstract][Full Text] [Related]
5. Are all statins the same? Focus on the efficacy and tolerability of pitavastatin.
da Silva PM
Am J Cardiovasc Drugs; 2011; 11(2):93-107. PubMed ID: 21446776
[TBL] [Abstract][Full Text] [Related]
6. Pitavastatin: efficacy and safety profiles of a novel synthetic HMG-CoA reductase inhibitor.
Kajinami K; Takekoshi N; Saito Y
Cardiovasc Drug Rev; 2003; 21(3):199-215. PubMed ID: 12931254
[TBL] [Abstract][Full Text] [Related]
7. Pitavastatin: novel effects on lipid parameters.
Chapman MJ
Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
[TBL] [Abstract][Full Text] [Related]
8. Pitavastatin: a new HMG-CoA reductase inhibitor for the treatment of hypercholesterolemia.
Ahmad H; Cheng-Lai A
Cardiol Rev; 2010; 18(5):264-7. PubMed ID: 20699675
[TBL] [Abstract][Full Text] [Related]
9. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of pitavastatin for the treatment of hypercholesterolemia.
Chan P; Shao L; Tomlinson B; Zhang Y; Liu ZM
Expert Opin Pharmacother; 2019 Jan; 20(1):103-113. PubMed ID: 30482061
[TBL] [Abstract][Full Text] [Related]
11. Pitavastatin in cardiometabolic disease: therapeutic profile.
Masana L
Cardiovasc Diabetol; 2013; 12 Suppl 1(Suppl 1):S2. PubMed ID: 23819752
[TBL] [Abstract][Full Text] [Related]
12. Randomized head-to-head comparison of pitavastatin, atorvastatin, and rosuvastatin for safety and efficacy (quantity and quality of LDL): the PATROL trial.
Saku K; Zhang B; Noda K;
Circ J; 2011; 75(6):1493-505. PubMed ID: 21498906
[TBL] [Abstract][Full Text] [Related]
13. Pitavastatin calcium: clinical review of a new antihyperlipidemic medication.
Yee LL; Wright EA
Clin Ther; 2011 Aug; 33(8):1023-42. PubMed ID: 21816477
[TBL] [Abstract][Full Text] [Related]
14. Pitavastatin and carbohydrate metabolism: what is the evidence?
Filippatos TD; Elisaf MS
Expert Rev Clin Pharmacol; 2016 Jul; 9(7):955-60. PubMed ID: 26967972
[TBL] [Abstract][Full Text] [Related]
15. Pitavastatin: the newest HMG-CoA reductase inhibitor.
Watson KE
Rev Cardiovasc Med; 2010; 11(1):26-32. PubMed ID: 20495513
[TBL] [Abstract][Full Text] [Related]
16. Pitavastatin: efficacy and safety in intensive lipid lowering.
Hayashi T; Yokote K; Saito Y; Iguchi A
Expert Opin Pharmacother; 2007 Oct; 8(14):2315-27. PubMed ID: 17927486
[TBL] [Abstract][Full Text] [Related]
17. Pitavastatin: a new 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor for the treatment of hyperlipidemia.
Baker WL; Datta R
Adv Ther; 2011 Jan; 28(1):13-27. PubMed ID: 21170619
[TBL] [Abstract][Full Text] [Related]
18. The clinical impact of pitavastatin: comparative studies with other statins on LDL-C and HDL-C.
Teramoto T
Expert Opin Pharmacother; 2012 Apr; 13(6):859-65. PubMed ID: 22332608
[TBL] [Abstract][Full Text] [Related]
19. Clinical benefits of pitavastatin: focus on patients with diabetes or at risk of developing diabetes.
Barrios V; Escobar C
Future Cardiol; 2016 Jul; 12(4):449-66. PubMed ID: 27076402
[TBL] [Abstract][Full Text] [Related]
20. New evidence on pitavastatin: efficacy and safety in clinical studies.
Teramoto T; Shimano H; Yokote K; Urashima M
Expert Opin Pharmacother; 2010 Apr; 11(5):817-28. PubMed ID: 20201733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
